SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance

U.S. Markets open in 6 hrs 44 mins

Sanofi (SNY)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
45.90+1.81 (+4.11%)
At close: 4:02PM EDT
People also watch
NVSGSKAZNLLYNVO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close44.09
Open46.11
Bid0.00 x
Ask0.00 x
Day's Range45.72 - 46.16
52 Week Range36.81 - 46.16
Volume3,973,977
Avg. Volume1,483,754
Market Cap114.63B
Beta0.75
PE Ratio (TTM)23.75
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.58 (3.46%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Mylan Tried to ‘Squelch’ EpiPen Rival, Sanofi Says in Lawsuit
    Bloomberg14 hours ago

    Mylan Tried to ‘Squelch’ EpiPen Rival, Sanofi Says in Lawsuit

    Mylan NV engaged in a campaign to squash a rival to its EpiPen allergy treatment and artificially inflate the price of the drug to maintain a market monopoly, French drugmaker Sanofi said in a lawsuit ...

  • TheStreet.com14 hours ago

    Sanofi Sues Mylan Over EpiPen Practices

    French multinational pharmaceutical company Sanofi on Monday filed a lawsuit against U.S. company Mylan.

  • Reuters15 hours ago

    Sanofi files U.S. antitrust lawsuit against Mylan over EpiPen

    France's Sanofi SA on Monday sued Mylan NV, accusing the pharmaceutical company of engaging in illegal conduct to squelch competition to its EpiPen allergy treatment, which has been at the center of a public debate over drug prices. In a lawsuit filed in federal court in Trenton, New Jersey, Sanofi said Mylan caused it to lose hundreds of millions of dollars in sales by erecting barriers to U.S. consumers' access to and use of a rival product, Auvi-Q.